Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Add like
Add dislike
Add to saved papers

End-On Bridging Dinitrogen Complex of Scandium.

The first (N═N)2- complex of a rare-earth metal with an end-on dinitrogen bridge, {K(crypt)}2 {[(R2 N)3 Sc]2 [μ-η1 :η1 -N2 ]} (crypt = 2.2.2-cryptand, R = SiMe3 ), has been isolated from the reduction of Sc(NR2 )3 under dinitrogen at -35 °C and characterized by X-ray crystallography. The structure differs from the characteristic side-on structures previously observed for over 40 crystallographically characterized rare-earth metal (N═N)2- complexes of formula [A2 Ln(THF)x ]2 [μ-η2 :η2 -N2 ] (Ln = Sc, Y, and lanthanides; x = 0, 1; A = anionic ligand such as amide, cyclopentadienide, and aryloxide). The 1.221(3) Å N-N distance and the 1644 cm-1 Raman stretch are consistent with the presence of an (N═N)2- bridge. The observed paramagnetism of the complex by Evans method measurements is consistent with DFT calculations that suggest a triplet (3 A2 ) ground state in D3 symmetry involving two degenerate Sc-N2 -Sc bonding orbitals. Upon brief exposure of the orange Sc3+ bridging dinitrogen complex to UV-light, photolysis to form the monomeric Sc2+ complex, [K(crypt)][Sc(NR2 )3 ], was observed. Conversion of the Sc2+ complex to the Sc3+ dinitrogen complex was not observed with this crypt system, but it did occur with the 18-crown-6 (crown) analog which formed {K(crown)}2 {[(R2 N)3 Sc]2 [μ-η1 :η1 -N2 ]}. This suggests the importance of the alkali metal chelating agent in the reversibility of dinitrogen binding in this scandium system.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app